Still confirming the accuracy of this--------- It appears

New Post Public Reply Private Reply Replies (2) Message Board
CGC
824
Still confirming the accuracy of this It appears that thousands of health care professionals across the globe have come together to take a collective stand for increased access to covid treatments for their patients, among other things.


Thousands of Physicians and Medical Scientists Sign “Rome Declaration” in Protest, Launch New Information Platform (The actual Declaration is available through a link at the bottom of the page.)


______________________________
'Over 4,600 physicians and medical scientists worldwide have signed the “Rome Declaration” to alert citizens about the deadly consequences of Covid-19 policy makers’ and medical authorities’ unprecedented behavior; behavior such as denying patient access to lifesaving early treatments, disrupting the sacred, physician-patient relationship and suppressing open scientific discussion for profits and power.'

An excerpt:

WHEREAS, there is an unprecedented assault on our ability to care for our patients;

WHEREAS, public policy makers have chosen to force a “one size fits all” treatment strategy, resulting in needless illness and death, rather than upholding fundamental concepts of the individualized, personalized approach to patient care which is proven to be safe and more effective;

WHEREAS, physicians and other health care providers working on the front lines, utilizing their knowledge of epidemiology, pathophysiology and pharmacology, are often first to identify new, potentially life saving treatments;

WHEREAS, physicians are increasingly being discouraged from engaging in open professional discourse and the exchange of ideas about new and emerging diseases, not only endangering the essence of the medical profession, but more importantly, more tragically, the lives of our patients;

WHEREAS, thousands of physicians are being prevented from providing treatment to their patients, as a result of barriers put up by pharmacies, hospitals, and public health agencies, rendering the vast majority of healthcare providers helpless to protect their patients in the face of disease. Physicians are now advising their patients to simply go home (allowing the virus to replicate) and return when their disease worsens, resulting in hundreds of thousands of unnecessary patient deaths, due to failure-to-treat;

WHEREAS, this is not medicine. This is not care. These policies may actually constitute crimes against humanity.

RESOLVED, that physicians must defend their right to prescribe treatment, observing the tenet FIRST, DO NO HARM. Physicians shall not be restricted from prescribing safe and effective treatments.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 51

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 197

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
AVANT BIO Beef Up Team with Heavyweights Lio, Vanek

Updated Category News Views 122

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Continue Reading
Massive $1B Jobs Initiative Fights AI Automation Impact

Updated Category News Views 40

Initiative Tackles Economic Shifts Head-On AI and automation are turning the job market upside down, and more than 20 foundations and philanthropies are throwing their weight behind a $1 billion initiative called All In For Jobs. Their aim? Connect half a million Americans to stable, decent-paying jobs and prepare communities to face the daunting transition imposed by...

Continue Reading
Natural Field Reinvents Supplement Delivery at SupplySide

Updated Category News Views 29

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Continue Reading
Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Updated Category News Views 54

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Continue Reading
Parloa's AI Agents Boost SAP Customer Experience

Updated Category News Views 145

AI Meets SAP in Customer Experience Revolution Alright, let's cut through the tech chatter. Parloa’s Agent Management Platform has hitched its wagon to SAP as a spiffy Solution Extension. This isn't just tech fluff—it’s a big step for scratching that CX itch companies have. By merging Parloa's AI magic with SAP's existing mojo, businesses get a toolset to enhance...

Continue Reading
Innventure Faces Legal Scrutiny Over DarkNX Debacle

Updated Category News Views 70

Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...

Continue Reading
GrOwnValve's Personalized Valves Pass Safety Milestone

Updated Category News Views 58

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Continue Reading
Fair Play in Focus: SYNA, CSR, VCTR, EFSI Deals Scrutinized

Updated Category News Views 77

The Corporate Buzz: Deals Under the Microscope Riding the rollercoaster of mergers and acquisitions ain't new in the stock market realm. But when the stakes seem one-sided, alarms start ringing. Halper Sadeh LLC, a firm that cuts its teeth on this kind of corporate sleuthing, is all hands on deck probing a slew of big deals involving Synaptics (NASDAQ:SYNA), Centerspace...

Continue Reading

Top 5 Most Recently Viewed Articles

Perspective Therapeutics Enhances [212Pb]VMT01 for Melanoma Treatment

Updated Category News Views 63

Overview of [212Pb]VMT01 Developments [212Pb]VMT01 has emerged as a promising candidate in the realm of radiopharmaceutical therapy. Recent initial results from the Phase 1/2a trial highlight its safety and efficacy, particularly in patients with advanced melanoma. Significantly, the trial showed that at doses of 3.0 mCi and 5.0 mCi, patients experienced no dose-limiting...

Continue Reading
Revolutionizing Visualization: STC AI's Impact on Presentations

Updated Category News Views 231

Transforming Data Visualization with STC AI In today's fast-paced world, where data is central to decision-making, being able to convey information in a clear and engaging manner is essential. Unfortunately, many professionals struggle with this crucial skill. Enter STC AI, a revolutionary free PowerPoint add-in created by Storytelling with Charts. This powerful tool is...

Continue Reading
The Metals Company (TMC): A Promising Project Unveiled

Updated Category News Views 196

Understanding The Metals Company's Recent Developments The Metals Company Inc shares are seeing an upward trend following notable announcements. Two economic studies have been released, indicating a staggering total project value of $23.6 billion and revealing mineral reserves that are pivotal for their polymetallic nodule project. The Polymetallic Nodule Project Overview...

Continue Reading
Exploring the Growth and Trends in the Global Chip Manufacturing Sector

Updated Category News Views 235

Overview of Chip Manufacturing Market Dynamics The global chip manufacturing market is experiencing remarkable growth, driven by technological advancements and an increased demand for semiconductors across versatile industries. With an estimated value of approximately USD 500 billion, it is expected to double, reaching nearly USD 1 trillion by 2034, indicating a solid...

Continue Reading
Sempra Earns Spot as a Top Global Company for 2024 Recognition

Updated Category News Views 168

Sempra Celebrated as One of the World's Best Companies Sempra (NYSE: SRE) has proudly landed a spot on TIME Magazine's prestigious list of the World's Best Companies for the year 2024. This esteemed recognition, determined in collaboration with Statista Inc., highlights Sempra's place among top global companies based on three vital pillars: employee satisfaction, revenue...

Continue Reading